Comparison

ulodesine-bcx4208

Item no. V3307-100mg
Manufacturer InvivoChem LLC
CASRN 548486-59-5
Amount 100 mg
Quantity options 10 mg 250 mg 25 mg 50 mg
Category
Type Biochemicals
Specific against other
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Available
Description
InvivoChem Cat #:V3307CAS #:548486-59-5Purity >=98%

Description: Ulodesine (formerly also known as BCX4208) is a novel and potent inhibitor of purine nucleoside phosphorylase (PNP) with an IC50 of 0.5 nM. It is is currently being developed by Biocryst as a once-daily oral, chronic treatment for gout. Ulodesine acts at the upstream of xanthine oxidase in the purine metabolism pathway to reduce the production of serum uric acid (sUA) by inhibiting PNP. BCX-4208 is currently in early clinical investigation in psoriasis and gout.

Description:

References: 2018 May; 27(5):437-444.

References:


Molecular Weight (MW)
264.28
Formula
C12H16N4O3
CAS No.
548486-59-5
Storage
-20C for 3 years in powder form
-80C for 2 years in solvent
Solubility (In vitro)
DMSO: >= 10mg/mL
Water: N/A
Ethanol: N/A
Chemical Name
7-(((3R, 4R)-3-hydroxy-4-(hydroxymethyl)pyrrolidin-1-yl)methyl)-3H-pyrrolo[3, 2-d]pyrimidin-4(5H)-one
Synonyms
BCX4208; BCX 4208; BCX-4208; DADMe-immucillin H
SMILES Code
O=C1C(NC=C2CN3C[CH](O)[CH](CO)C3)=C2N=CN1

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 100 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close